Overview
CELZ market data
Price History
CELZ price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.52 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.96 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -58,762.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.62 – $6.25 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $8.2M · P/B 0.67 · P/S 1,362.46.
Company News
12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga · Aug 10, 2026, 12:06 PM
Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving PremarketBenzinga · Aug 10, 2026, 8:59 AM
12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · Aug 7, 2026, 12:05 PM
12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga · Aug 6, 2026, 9:06 PM
Creative Medical Technology Stock Surges After Key Patent WinBenzinga · Aug 6, 2026, 7:13 PM
Creative Medical Tech shares are trading higher after the company announced it received Notice of Allowance from the United States Patent and Trademark Office for a U.S. patent application titled "Suppression of Diabetes Using Exosomes From Stem Cell Programmed Myeloid Cells"Benzinga · Aug 6, 2026, 1:30 PM
Creative Medical Receives Notice Of Allowance From USPTO For US Patent Application Titled Suppression Of Diabetes Using Exosomes From Stem Cell Programmed Myeloid CellsBenzinga · Aug 6, 2026, 1:16 PM
Why SiTime Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving PremarketBenzinga · Aug 6, 2026, 8:55 AM
Creative Medical Technology shares are trading higher after the company announced it has received a Notice of Allowance for a US patent titled "SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS".Benzinga · Aug 5, 2026, 8:52 PM
Creative Medical Technologies Has Received A Notice Of Allowance For A U.S. Patent Titled "SUPPRESSION OF DIABETES USING EXOSOMES FROM STEM CELL PROGRAMMED MYELOID CELLS"Benzinga · Aug 5, 2026, 7:58 PM